fbpx

Help Protect Infants Against Pneumococcal Disease

Learn about no-cost study evaluating a new vaccine that may to help protect babies from common and serious infections like ear infections, pneumonia, and meningitis.

CHECK INFANT’S ELIGIBILITY

What is Pneumococcal Disease?

Pneumococcal disease is caused by a type of bacteria that can lead to infections such as ear infections, pneumonia, blood infections, and meningitis.

These infections are especially serious in young children and infants because their immune systems are still developing. Even common illnesses like ear infections can sometimes lead to hospital stays or long-term health problems.

Pneumococcal bacteria spread easily through coughing, sneezing, or close contact. Vaccines are the best way to help protect children from these infections.

CHECK INFANT’S ELIGIBILITY

FILL OUT THE FORM IF YOUR INFANT MEETS THE FOLLOWING CRITERIA

● Is 3 months of age or younger
● Is generally healthy
● Can attend regular clinic visits over the next year
CHECK INFANT’S ELIGIBILITY

About the Study

Pneumococcal disease can cause ear infections, pneumonia, blood infections, and meningitis in young children. Vaccines are the best protection, and this study is testing a new option to provide broader coverage.

In this study, babies will receive either the investigational 21-valent pneumococcal vaccine (PCV21) or Prevnar 20, a vaccine already approved for use.

Your child will also receive all routine childhood vaccines such as DTaP, Hib, Hepatitis B, Polio, and Rotavirus on schedule at no cost. This ensures their regular protection continues.

Participants will get four doses of pneumococcal vaccine at 2, 4, 6, and 12 to 15 months of age, with follow-up visits. Study care is provided at no cost, and compensation may be available for time and travel.

CHECK INFANT’S ELIGIBILITY

Why Participate?

Pneumococcal disease can cause ear infections, pneumonia, blood infections, and meningitis in young children. This clinical trial is testing an investigational 21-valent pneumococcal vaccine (PCV21) in infants, comparing it to an already approved vaccine.

If your baby qualifies and you choose to participate, they will receive:

No-cost Study Care

All study-related care from experienced doctors, nurses, and research staff at no cost.

Exams & Vaccinations

The study includes routine checkups, lab work, and four doses of either the investigational vaccine or the approved vaccine. Your baby will also receive recommended childhood vaccines at no cost.

Compensation

You may be eligible to receive compensation for your time and travel.
CHECK INFANT’S ELIGIBILITY

Chat With a Research Coordinator

Fill out the form below, and you will be advised if your infant is eligible or not. If they meet the initial screening criteria, you will be contacted by someone from a research location near you. If they do not meet the minimum criteria, please still submit the form. The study criteria may change in the future, and they may become eligible later.

© 2025 Accelerate Recruitment | Privacy Policy | Legal Notice